ロード中...
Discovery of 2,3’-Diindolylmethanes as a Novel Class of PCSK9 Modulators
Proprotein convertase subtilisin/kexin type 9 (PCSK9) promotes the degradation of low density lipoprotein receptor (LDLR). Anti-PCSK agents have been approved for the treatment of hypercholesterolemia. We recently discovered a series of small-molecule PCSK9 modulators that contains a relatively smal...
保存先:
| 出版年: | Bioorg Med Chem Lett |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6690802/ https://ncbi.nlm.nih.gov/pubmed/31227343 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmcl.2019.06.014 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|